DNA Testing Is a Slippery Slope
By Russell Saunders,
The Daily Beast
| 04. 14. 2015
Untitled Document
Let’s say you have a whole lot of money.
Let’s say you have so much money that, even after you’ve purchased a basketball team and a chain of movie theaters, you still have enough cash left over to invest in a maverick approach to your own health care. Should you sink an unspecified sum into ordering every test you can find in the off chance that sooner or later you’re going to detect something valuable?
Mark Cuban says “yes.”
In a series of tweets posted at the beginning of this month, the media baron and basketball franchisee admonished his followers that, if they were sufficiently affluent, they should order blood tests for “everything available” on a quarterly basis in order to establish a baseline for their own health. In the event of some deviation from the any given person’s aggregate normal values, it might detect some abnormality earlier than it would otherwise be found when it started creating symptoms.
Looking at Cuban’s page now, it seems the tweets in question from April 1 have gone missing. But...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...